Lipase Enzyme prices in the US market have steadily risen through mid-Q3, driven by persistent demand from pharmaceutical, food, and specialty chemical sectors. Supply chain disruptions, rising production costs, and limited feedstock availability have intensified price pressures. With growing health concerns and festive season demand for Lipase enzyme, consumption is surging. Despite stable logistics, demand supply imbalances and global trade dynamics continue to push prices upward, with analysts forecasting further escalation ahead.
